Page de couverture de Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs

Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs

Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs

Auteur(s): Annenberg Center for Health Sciences
Écouter gratuitement

À propos de cet audio

 Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.Annenberg Center for Health Sciences Hygiène et mode de vie sain Troubles et maladies
Épisodes
  • Clinical Case Vignettes

    Clinical Case Vignettes
    Nov 14 2024
    • Initiating triheptanoin
    • Dosing modification to improve tolerability
    Voir plus Voir moins
    10 min
  • Optimizing Triheptanoin Therapy

    Optimizing Triheptanoin Therapy
    Nov 14 2024
    • Clinical safety and efficacy
    • Initiation and titration
    • Administration considerations
    • Individualizing treatment
    Voir plus Voir moins
    19 min
  • Historical Treatment; Introduction of Triheptanoin

    Historical Treatment; Introduction of Triheptanoin
    Nov 14 2024
    • Dietary modification
    • MCT supplementation
    • Triheptanoin mechanism of action
    Voir plus Voir moins
    6 min
Pas encore de commentaire